SCHEMBL6825323

SCHEMBL6825323

COC(=O)Cc1c(C)[nH]c2ccc(O)cc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SPR P35270 1/20 0.60
CYP1A2 P05177 1/20 0.57
CYP3A4 P08684 1/20 0.57
CYP2D6 P10635 1/20 0.57
CYP2C9 P11712 1/20 0.57
HTR1D P28221 1/20 0.57
MAPK1 P28482 1/20 0.57
CYP2C19 P33261 1/20 0.57
HTR7 P34969 1/20 0.57
HTR3A P46098 1/20 0.57
HTR6 P50406 1/20 0.57
HSD17B10 Q99714 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
AKR1C2 P52895 1/20 0.56
RAD52 P43351 1/20 0.54
BLM P54132 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
GAA P10253 5/20 0.54
MAPT P10636 4/20 0.54
KDM4E B2RXH2 3/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6222629 0.87 GAA (0.63) SPRCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL853772 0.86 SPR (0.65) SPRCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL30604527 0.84 AKR1C2 (0.78) CYP1A2CYP3A4CYP2D6CYP2C9HTR1D
SCHEMBL6825151 0.84 AKR1C2 (0.78) CYP1A2CYP3A4CYP2D6CYP2C9HTR1D
SCHEMBL1757929 0.84 AKR1C2 (0.54) HTR7HTR6AKR1C2GAAMAPT
SCHEMBL3005298 0.84 AKR1C2 (0.54) SPRAKR1C2GAAMAPTKDM4E
SCHEMBL2003333 0.84 KDM4E (0.75) SPRCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL8529584 0.83 PTPN5 (0.62) HSD17B10TDP1AKR1C2GAAMAPT
SCHEMBL27380744 0.82 HTR7 (0.64) SPRCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL8298627 0.81 AKR1C2 (0.61) HTR1DHTR6HSD17B10AKR1C2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004089915-A1 PIPERAZINE DERIVATIVE RENIN INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2004-10-21 WO disclosed